They found that for FDA approved GLP-1s for weight loss, liraglutide (Saxenda) and semaglutide (Wegovy), the percent of side effects reported was as follows: Nausea: 42.2% Diarrhea: 21.9% Vomiting: also 21.9% Constipation: 8.4% They report that although the incidence of side effects were similar among medications, semaglutide had the greatest risk of nausea, diarrhea, and vomiting, whereas liraglutide had the greatest risk of upper abdominal pain
So when an employer takes that away, it is not a benefits decision
Table of Contents: What are GLP-1 injections, and how do they work for weight loss
Plus, GLP-1s are believed to dampen dopamine signaling, which might actually put the lid on initiative and drive and competitiveness, Ziyad Al-Aly, a researcher at Washington University in St
Phillips Aesthetics, we are committed to offering advanced, medically supervised weight management solutions to help you look and feel your best